Kempharm Stock Options

KMPH -  USA Stock  

USD 9.08  0.14  1.57%

Kempharm's option chain provides insight into all available option contracts written on Kempharm's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Kempharm's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Kempharm option contract.

Search Stock Options 

 
Refresh

In The Money vs. Out of Money Option Contracts on Kempharm

Analyzing Kempharm's in-the-money options over time can help investors to take a profitable long position in Kempharm regardless of its overall volatility. This is especially true when Kempharm's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Kempharm's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Kempharm's stock while costing only a fraction of its price.
Kempharm's latest option contracts expiring on 2021-10-15 are carrying combined implied volatility of 115.51 with a put-to-call open interest ratio of 0.35 over 14 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2021-10-15. The current put volume is at 263, with calls trading at the volume of 275. This yields a 0.96 put-to-call volume ratio. The Kempharm option chain provides detailed quote and price information for the current Kempharm option contracts. It shows all of Kempharm's listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2021-10-15 Option Contracts

Kempharm option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Kempharm's lending market. For example, when Kempharm's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Kempharm, he or she must hedge the risk by shorting Kempharm stock over its option's life.
The chart above shows Kempharm's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Kempharm's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Kempharm's option, there is no secondary market available for investors to trade.

Kempharm Maximum Pain Price accross 2021-10-15 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Kempharm close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Kempharm's stock options are financial instruments that give investors the right to buy or sell shares of Kempharm common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Kempharm stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Kempharm's stock price goes up or down, the stock options follow.
Please see Stocks Correlation.
Please note that buying 'in-the-money' options on Kempharm lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Kempharm's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Kempharm contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Kempharm Stock moves the wrong way.
The current Net Income Common Stock is estimated to decrease to about (13.8 M)

Kempharm In The Money Call Balance

When Kempharm's strike price is surpassing the current stock price, the option contract against Kempharm stock is said to be in the money. When it comes to buying Kempharm's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' options written on Kempharm are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Kempharm Current Options Market Mood

Kempharm's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Kempharm Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Kempharm's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Kempharm's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Kempharm's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Kempharm Option Chain

When Kempharm's strike price is surpassing the current stock price, the option contract against Kempharm stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
2021-10-152021-11-192022-01-212022-02-182022-05-202023-01-202024-01-19
Kempharm's option chain is a display of a range of information that helps investors for ways to trade options on Kempharm. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Kempharm. It also shows strike prices and maturity days for a Kempharm against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Call
2021-10-15 CALL at $2.50.99150.004102021-10-156.3 - 6.90.0In
Call
2021-10-15 CALL at $5.00.91930.0314232021-10-153.8 - 4.33.7In
Call
2021-10-15 CALL at $7.50.81850.1198652021-10-151.6 - 2.051.6In
Call
2021-10-15 CALL at $10.00.38320.18033322021-10-150.5 - 0.750.5Out
Call
2021-10-15 CALL at $12.50.15970.09512712021-10-150.15 - 0.250.19Out
Call
2021-10-15 CALL at $15.00.06860.0475322021-10-150.05 - 0.10.15Out
Call
2021-10-15 CALL at $17.50.04360.029222021-10-150.05 - 0.050.05Out
 Put
2021-10-15 PUT at $5.0-0.13660.0205102021-10-150.05 - 2.80.05Out
 Put
2021-10-15 PUT at $7.5-0.19660.1151632021-10-150.15 - 0.450.35Out
 Put
2021-10-15 PUT at $10.0-0.55260.1334872021-10-151.5 - 2.251.75In
 Put
2021-10-15 PUT at $12.5-0.71910.0911662021-10-153.5 - 4.43.83In
 Put
2021-10-15 PUT at $15.0-0.75920.0659222021-10-155.9 - 6.76.45In
 Put
2021-10-15 PUT at $17.5-0.74590.053472021-10-158.2 - 10.09.14In

Kempharm Net Income Common Stock Over Time

The amount of net income (loss) for the period due to common shareholders. Typically differs from Net Income to the parent entity due to the deduction of Preferred Dividends.
 Net Income Common Stock 
Share
      Timeline 

Kempharm Net Income Common Stock USD Over Time

Net Income Common Stock in USD; converted by US Dollar Exchange Rate.
 Net Income Common Stock USD 
Share
      Timeline 

Kempharm Historical Liabilities

While analyzing the current debt level is an essential aspect of forecasting the current year budgeting needs of Kempharm, understanding its historical liability is critical in projecting Kempharm's future earnings, especially during periods of low and high inflation and deflation. Many analysts look at the trend in assets and liabilities and evaluate how Kempharm uses its financing power over time.

Kempharm Investors Sentiment

The influence of Kempharm's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Kempharm. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - KMPH

Kempharm Investor Sentiment

Most of Macroaxis users are now bullish on Kempharm. What is your trading attitude regarding investing in Kempharm? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Kempharm using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Stocks Correlation. Note that the Kempharm information on this page should be used as a complementary analysis to other Kempharm's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Kempharm Stock analysis

When running Kempharm price analysis, check to measure Kempharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kempharm is operating at the current time. Most of Kempharm's value examination focuses on studying past and present price action to predict the probability of Kempharm's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kempharm's price. Additionally, you may evaluate how the addition of Kempharm to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
The market value of Kempharm is measured differently than its book value, which is the value of Kempharm that is recorded on the company's balance sheet. Investors also form their own opinion of Kempharm's value that differs from its market value or its book value, called intrinsic value, which is Kempharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kempharm's market value can be influenced by many factors that don't directly affect Kempharm underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kempharm's value and its price as these two are different measures arrived at by different means. Investors typically determine Kempharm value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kempharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.